Tequin (gatifloxacin) is now contraindicated for diabetes patients

Tequin (gatifloxacin) is now contraindicated for diabetes patients.

In January, we told you about the many reports of hyper- and hypoglycemia associated with Tequin...especially in diabetes patients.

Also watch for patients at risk for blood glucose problems with Tequin due to advanced age or renal insufficiency.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote